title: Modulation of vascular function by neuropeptide Y during development of hypertension in spontaneously hypertensive rats.
abstract: Neuropeptide Y (NPY) is a sympathetic cotransmitter and a platelet-derived factor which causes vasoconstriction, potentiation of norepinephrine (NE) action, and vascular mitogenic effects. Reciprocally, NE markedly enhances the actions of NPY. We studied vasopressor effects of NPY and sources of peptide release during the development of hypertension in spontaneously hypertensive rats (SHR). Conscious SHR (4 and 16 weeks old) had higher resting plasma levels of NE and epinephrine than age-matched Wistar-Kyoto (WKY) rats, but similar NPY immunoreactivity (NPY-ir) levels in platelet-poor plasmas (PPP). In both strains, NPY-ir levels in PPP were higher in 4-week-old than in older rats. However, at all ages (4-24 weeks) SHR had markedly elevated NPY-ir content in platelet-rich-plasmas than WKY rats, although levels declined with age and hypertension. In the superior mesenteric artery, NPY-ir content (per mg) was significantly higher in 4-week-old but lower in 16-week-old SHR than in WKY rats, suggesting greater sympatho-neural NPY stores and release (leading to depletion) during the development of hypertension. Four-week-old SHR also tended to have higher NPY-ir content in the adrenal medullae and coeliac ganglia but a lower content in the kidney than WKY rats; these differences disappeared with age. Pressor responsiveness to alpha-agonists and NPY were similar in both strains at 4 weeks. While unchanged by age in WKY rats, adrenergic and NPY-mediated vasopressor responses became augmented in 16- to 24-week-old SHR (compared with WKY rats); this hyperresponsiveness was not completely abolished by ganglionic blockade and not observed with vasopressin.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, D.C. 20007.
authors.forename: Z
authors.initials: Z
authors.lastname: Zukowska-Grojec
authors.forename: M
authors.initials: M
authors.lastname: Golczynska
authors.forename: G H
authors.initials: GH
authors.lastname: Shen
authors.forename: A
authors.initials: A
authors.lastname: Torres-Duarte
authors.forename: M
authors.initials: M
authors.lastname: Haass
authors.forename: C
authors.initials: C
authors.lastname: Wahlestedt
authors.forename: A K
authors.initials: AK
authors.lastname: Myers
mesh_terms: D000313:Adrenal Medulla / Q000378:metabolism; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000818:Animals; D001792:Blood Platelets / Q000378:metabolism; D002395:Catecholamines / Q000097:blood; D006973:Hypertension / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D009478:Neuropeptide Y / Q000097:blood / Q000502:physiology*; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D013564:Sympathetic Nervous System / Q000378:metabolism
chemical_list: D000316:Adrenergic alpha-Agonists; D002395:Catecholamines; D009478:Neuropeptide Y